Legend Biotech (LEGN) Debt Ratio (2021 - 2025)
Legend Biotech (LEGN) posted Debt Ratio of 0.18 for Q4 2025, up 120.67% on a QoQ basis from 0.08 in Q3 2025, and up 2.06% year-over-year from 0.18 in Q4 2024.
Legend Biotech (LEGN) has 5 years of Debt Ratio data on file, last reported at 0.18 in Q4 2025.
- In Q4 2025, Debt Ratio rose 2.06% year-over-year to 0.18; the TTM figure through Dec 2025 stood at 0.18 (up 2.06% YoY), while the FY2025 annual figure was 0.18, up 2.06% from the prior year.
- Debt Ratio grew to 0.18 in Q4 2025, from 0.08 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.22 in Q1 2023 and bottomed at 0.0 in Q2 2021.
- A 5-year average of 0.15 and a median of 0.16 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio jumped 82.19% — and 2025, when it plunged 51.19%.
- Year by year, Debt Ratio stood at 0.11 in 2021, then soared by 82.19% to 0.2 in 2022, then dropped by 22.37% to 0.15 in 2023, then increased by 18.5% to 0.18 in 2024, then rose by 2.06% to 0.18 in 2025.
- The last three Debt Ratio figures came in at 0.18 (Q4 2025), 0.08 (Q3 2025), and 0.18 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.18 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.18 |
| Mar 31, 2025 | 0.19 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | 0.22 |
| Dec 31, 2022 | 0.20 |
| Mar 31, 2022 | 0.12 |
| Dec 31, 2021 | 0.11 |
| Sep 30, 2021 | 0.09 |
| Jun 30, 2021 | 0.00 |